Skip to main content
. 2022 May 23;6(15):4506–4515. doi: 10.1182/bloodadvances.2021006713

Figure 2.

Figure 2

Cumulative best overall response based on IRC according to cycle. Patients who received Isa-Kd (A) compared with those who received Kd (B) (intention-to-treat population). BOR, best overall response.